Versant Venture Management, LLC - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 120 filers reported holding GRITSTONE ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
Versant Venture Management, LLC ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$6,125,178
-11.8%
3,561,1500.0%3.26%
-60.5%
Q2 2023$6,944,243
-29.9%
3,561,1500.0%8.24%
-60.1%
Q1 2023$9,899,997
-19.4%
3,561,1500.0%20.64%
-18.8%
Q4 2022$12,285,968
+34.2%
3,561,1500.0%25.42%
+62.9%
Q3 2022$9,152,000
+6.2%
3,561,1500.0%15.60%
+18.1%
Q2 2022$8,618,000
-41.3%
3,561,1500.0%13.21%
-9.8%
Q1 2022$14,672,000
-68.0%
3,561,1500.0%14.65%
-40.2%
Q4 2021$45,796,000
+5.9%
3,561,150
-11.1%
24.49%
+36.7%
Q3 2021$43,264,000
+6.5%
4,005,894
-10.0%
17.91%
+33.1%
Q2 2021$40,634,000
-3.2%
4,450,6380.0%13.46%
+64.7%
Q1 2021$41,970,000
+139.3%
4,450,6380.0%8.18%
+349.0%
Q4 2020$17,536,000
+113.3%
4,450,638
+43.4%
1.82%
+21.0%
Q3 2020$8,223,000
-100.0%
3,102,9290.0%1.50%
-49.2%
Q2 2020$20,603,449,000
+14.1%
3,102,9290.0%2.96%
-40.2%
Q1 2020$18,059,047,000
-35.1%
3,102,9290.0%4.95%
-40.9%
Q4 2019$27,833,273,000
+3.9%
3,102,9290.0%8.39%
-19.1%
Q3 2019$26,793,792,000
-22.5%
3,102,9290.0%10.37%
+2.9%
Q2 2019$34,566,629,0003,102,92910.07%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,450,638$17,536,0001.82%
EcoR1 Capital, LLC 3,421,287$13,480,0000.72%
FRAZIER MANAGEMENT LLC 2,061,758$8,123,0000.63%
BVF INC/IL 2,695,418$10,620,0000.42%
Column Group LLC 869,493$3,426,0000.31%
Avidity Partners Management LP 2,122,064$8,361,0000.27%
Redmile Group, LLC 3,059,794$12,056,0000.15%
SkyOak Wealth, LLC 69,778$275,0000.09%
Tekla Capital Management LLC 419,005$1,651,0000.06%
Blackstone Inc. 2,567,445$10,116,0000.04%
View complete list of GRITSTONE ONCOLOGY INC shareholders